ensartinib for advanced alk rearranged non-small cell lung cancer
Published 7 years ago • 478 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
3:26
a case of alk-rearranged non–small cell lung cancer
-
4:28
changing the treatment paradigm for alk-rearranged nsclc
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
3:12
diagnosis of metastatic alk-rearranged nsclc
-
6:28
new standard of care for alk-rearranged nsclc
-
6:28
targeted therapy for alk-positive nsclc: a practical case study | biomarker-guided therapy in nsc...
-
6:37
ascend-4: upfront ceritinib in alk-rearranged nsclc
-
7:02
crizotinib for alk-rearranged nsclc
-
1:23
ascend-1 and ascend-2: ceritinib for alk-rearranged nsclc and baseline brain metastases
-
2:01
grace targeted therapies lung cancer 2021 - data learned from ensartinib for ros1 in clinical trial?
-
5:51
alta-1l: brigatinib vs crizotinib for alk advanced non small cell lung cancer patients
-
8:02
updates informing the management of alk-rearranged mnsclc
-
8:16
alta ii trial of brigatinib in alk-rearranged nsclc
-
2:49
case presentation: alk-rearranged metastatic nsclc
-
5:19
brigatinib at disease progression of alk-rearranged nsclc
-
6:02
alk-rearranged lung cancer
-
4:16
alta trial for relapsed/refractory alk nsclc
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
1:34
second-line treatments in alk-rearranged nsclc